Barry Strasnick

Barry Strasnick, MD, FACS; Director, is a professor at Eastern Virginia Medical School and serves as the Chairman of the Department of Otolaryngology, Head and Neck Surgery. Dr. Strasnick earned his medical degree at Baylor College of Medicine, and he completed residencies at the Baylor College of Medicine and UCLA School of Medicine, as well as a fellowship with The Otology Group in Nashville, Tennessee. Dr. Strasnick previously served as Chief Science Officer and Board Member for Tympany, a medical device company that produced the world’s first fully automated audiometer. He serves as Scientific Advisor for Tympanogen, a medical technology company that develops ear, nose and throat devices, and wound healing therapies. He has invented a number of implantable otologic devices and holds numerous patents in the field of hearing technology. In 1999, Dr. Strasnick authored legislation mandating universal hearing testing of all newborns in the state of Virginia and was responsible for protocol development and process implementation throughout all birthing facilities in Virginia. He previously served as Chairman of the Virginia Newborn Hearing Screening Commission.


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


ReAlta Life Sciences

ReAlta Life Sciences, Inc. is an early stage pharmaceutical company incorporated in late, 2018, and located in Norfolk, Virginia. ReAlta was initially formed as a joint venture between Children’s Hospital of The King’s Daughters, Children’s Specialty Group (170 multispecialty pediatricians) and Eastern Virginia Medical School. ReAlta is dedicated to addressing life-threatening medical needs through beneficial inhibition of the Complement System and Inflammatory Mechanisms. To support this mission, ReAlta has developed a New Class of Drugs that can address unmet medical needs through unique Multi-Modal Therapeutic Capabilities.


Employees

11-50

Links